GlassScriptPhysician profile
Janelle J Jensen
NPI 1619284213
$3,881.80
in general payments reported to CMS, 2019-2025
14 companies · $746 in 2025
The $746 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $1,237 · 2023: $796 · 2024: $749 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,290.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $841.80 | 2021-2025 | Qelbree, Qelbree |
| Abbvie INC. | $452.87 | 2022-2025 | |
| Corium, LLC | $449.72 | 2023-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $448.36 | 2021-2025 | Trintellix |
| Tris Pharma INC | $370.04 | 2023-2025 | Dyanavel Xr |
| Alkermes, INC. | $315.66 | 2021-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.57 | 2021-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $270.70 | 2022-2024 | Jornay Pm |
| E.R. Squibb & Sons, L.L.C. | $197.40 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $124.75 | 2022-2024 | Rexulti |
| Collegium Pharmaceutical, INC. | $58.36 | 2025 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $24.28 | 2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $19.61 | 2023 | Ingrezza |
| Noven Therapeutics, LLC | $16.68 | 2024 | Xelstrym, Secuado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janelle Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.